share_log

Ladenburg Thalmann Maintains Buy on Palisade Bio, Lowers Price Target to $16

Benzinga ·  May 16, 2023 08:23

Ladenburg Thalmann analyst Aydin Huseynov maintains Palisade Bio (NASDAQ:PALI) with a Buy and lowers the price target from $25 to $16.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment